In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux
- 18 August 2011
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 129 (4), e77-e82
- https://doi.org/10.1016/j.thromres.2011.07.026
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Rivaroxaban and false positive lupus anticoagulant testingThrombosis and Haemostasis, 2011
- The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban‐treated patients: results of an in vitro studyJournal of Thrombosis and Haemostasis, 2010
- Anticoagulation by factor Xa inhibitorsJournal of Thrombosis and Haemostasis, 2010
- New oral anticoagulants in developmentThrombosis and Haemostasis, 2010
- An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasmaThrombosis and Haemostasis, 2010
- Standardization and Clinical Utility of Thrombin-Generation AssaysSeminars in Thrombosis and Hemostasis, 2008
- DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profilesJournal of Thrombosis and Haemostasis, 2008
- Thrombin generation testing in routine clinical practice: are we there yet?British Journal of Haematology, 2008
- Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamberThrombosis and Haemostasis, 2007
- The measurement and application of thrombin generationBritish Journal of Haematology, 2005